Answers are grounded in this paper and cite their sources.
Cyclin-dependent kinases (CDKs) use multiple docking interactions to recognise their substrates and inhibitors, but how sequences between canonical interaction motifs contribute to these processes remains poorly understood. Here, we identify an auxiliary interaction element in the budding yeast CDK inhibitor Far1 and investigate its contribution to kinase inhibition and multisite phosphorylation. Combining AlphaFold3 modelling with biochemical assays and mutational analysis, we show that Far1 residues 310-319 (QLIRTADISC), located immediately downstream of the Cks1-binding phospho-threonine T306, contribute to inhibition of Clb5-Cdk1. In particular, the hydrophobic residues I312 and I317 are important for inhibitory potency, consistent with their predicted positions at the Cks1-Cdk1 interface. To investigate the functional consequences of this interaction in a substrate context, we introduced the Far1 sequence between two phosphorylation sites in a Sic1-derived substrate. This insertion increased the accumulation of doubly phosphorylated product by more than twofold, while reducing the overall phosphorylation rate. These findings suggest that sequences between canonical CDK recognition elements can provide auxiliary interactions that influence both kinase inhibition and substrate phosphorylation dynamics. Thus, the region between established docking motifs represents an additional determinant of CDK substrate processing and inhibitory activity.
No takes yet. Share an insight, caveat, or question.
Maljavin et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: